Although it is unclear whether PD-L1 can trigger reverse signals to tumor cells by its short cytoplasmic tail that does not have obvious signaling motifs, PD-L1 functions as an inhibitory receptor that protects cancer cells from immune-mediated cancer cell destruction and Fas-mediated killing (205). Here, CD274 is linked to neoplasm.